IRWD
Ironwood Pharmaceuticals Inc
Price:  
4.51 
USD
Volume:  
1,640,342.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IRWD WACC - Weighted Average Cost of Capital

The WACC of Ironwood Pharmaceuticals Inc (IRWD) is 6.2%.

The Cost of Equity of Ironwood Pharmaceuticals Inc (IRWD) is 8.15%.
The Cost of Debt of Ironwood Pharmaceuticals Inc (IRWD) is 4.40%.

Range Selected
Cost of equity 6.40% - 9.90% 8.15%
Tax rate 6.30% - 17.50% 11.90%
Cost of debt 4.00% - 4.80% 4.40%
WACC 5.2% - 7.2% 6.2%
WACC

IRWD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.55 0.91
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 9.90%
Tax rate 6.30% 17.50%
Debt/Equity ratio 0.87 0.87
Cost of debt 4.00% 4.80%
After-tax WACC 5.2% 7.2%
Selected WACC 6.2%